Drug Trial Radar · NCT05377554
Bevonescein for Intra-Operative Nerve Visualization in Head and Neck Surgery
Last checked: Nov 19, 2026Latest source record: Oct 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
154
Actual
Start
Apr 29, 2022
Primary completion
Oct 27, 2025
Study completion Nov 24, 2025
Sponsor
- Lead sponsor
- Alume Biosciences, Inc.Industry
- Sponsor type
- Industry
- First posted
- May 17, 2022
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Single (investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 16 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This protocol describes prospective, open-label, blinded, randomized controlled, multicenter pivotal studies to evaluate bevonescein.
Conditions
- Surgery
Interventions
BevonesceinDrug
Bevonescein will be infused during the pre-operative period.
Intraoperative Visualization using White Light Reflectance (WLR) with Fluorescence (FL) OverlayOther
Intra-operative real time nerve visualization will be undertaken using WLR with FL Overlay.
Intra-operative Visualization using White Light Reflectance (WLR)Other
Intra-operative real time nerve visualization will be undertaken using WLR.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Nerve ConspicuityTime frame: During surgery
- Length MeasurementTime frame: During Surgery
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Alume Biosciences
La Jolla, California
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.